Skip to content

The Impact of Different Potencies of Ammonium Carb on Allergic Rhinitis Symptoms: A Comparative Study

A Comparative Study Of The Centesimal Scale And Decimal Scale of Ammonium Carbonicum In Allergic Rhinitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079506
Enrollment
40
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J30- Vasomotor and allergic rhinitis

Interventions

Intervention1: Homoeopathic Medicine Ammonium Carbonicum Do Given To One Group Which Prepared In form Of Centesimal Scale Name Of Drug Ammonium Carbonicum : Case Where Ammonium Carbonicum Indicated

Sponsors

C.D.Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of all age groups & both sexes. Patient already diagnosed and taking treatment of other system of medicine but not getting relief. All socio-economic class should be taken in study.

Exclusion criteria

Exclusion criteria: Vasomotor rhinitis or nonallergic rhinitis. Anatomic rhinitis (E.g, deviated septum, choanal atresia, adenoid hypertrophy, foreign body, nasal tumor). Nasal polyps. Irregular follow up patients. Autoimmune disorder.

Design outcomes

Primary

MeasureTime frame
To Assess The Effectiveness Of Ammonium Carbonicum In Decimal Potency And Centesimal PotencyTimepoint: Homoeopathic Medicine Dose As Per Requirement Of The Cases Through Oral Route Within Time Duration Of 9 Months

Secondary

MeasureTime frame
Effectiveness Of Ammonium Carbonicum In Centesimal Potency And Decimal Potency Are Either it will be Similar And Either It will be DissimilarTimepoint: With In 9 Months

Countries

India

Contacts

Public ContactDr Rajesh Santosh Mahale

C.D.Pachchigar College Of Homoeopathic Medicine And Hospital

rajeshmahale4u@gmail.com9825290925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026